Medicaid Commission Calls for AMP-Based Drug Pricing

Drug Industry Daily
A A

A bipartisan commission has recommended changes to the Medicaid prescription drug reimbursement formula, including new methods of reporting drug prices and penalties for pharmaceutical firms that provide inaccurate pricing information.

To View This Article:

Login

Subscribe To Drug Industry Daily